Dynavax Technologies Corporation (DVAX)

Health Care > Major Pharmaceuticals

Price

  • Last Close
  • $ 14.45
    + 1.07
  • Trading Volume
  • 2,157,500
  • Market Cap
  • $ 856.3M
  • 52-Week High/Low
  • 20.76 - $4.45

Earnings

  • Earning
  • 2020 2021
    $ -0.68 -
  • 2021 P/E Ratio
  • Trailing Forward
    -19.68 -
  • Short share
  • Date Shares Ratio
    Sep 30, 2019 17958858 28.06

Gain

  • 30-day
  • DVAX -17.2%
    S&P 500 -0.32%
  • 90-day
  • -25.29%
  • 4.21%
  • 180-day
  • 44.03%
  • 10.34%
  • 52-Week
  • 179.92%
  • 26.59%

Dividend

  • Dividend
  • 0
  • Dividend Yield
  • ;0%
  • Outstanding
  • 63,996,900
  • 50 Day Avg Volume
  • 2557638

Calender

  • Fiscal Year End
  • Dec 31
  • Last Earning Date
  • Mar 09, 2021
  • Ex-Dividend Date
  • -
  • Current Year Beta
  • 1.74

Ratio

  • Debt To EQuity
  • 1.6
  • Return On Equity
  • -251.96%
  • Book Value
  • $0.58

Earnings

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Q1 0 -0.2 -0.6 -0.6 0.6 0.7 1 -0.5 -1.1 -1.1 -1.6 -1.7
Q2 0 -0.5 -0.7 -0.6 0.4 0.8 0.8 -0.9 -0.9 -0.9 -0.9 -3.4
Q3 0 -0.2 -0.5 -0.7 0.4 0.9 0.8 -1.1 -0.9 -1 -1.2 -0.6
Q4 0 0.2 -0.4 -0.6 0.4 0.6 0.7 -0.9 -0.9 -1.1 -0.2 -1.2
A 0 -0.7 -2.2 -2.6 1.8 2.9 3.3 -3.5 -3.8 -4.1 -3.9 -6.9

Dividend
+

Q1
Q2
Q3
Q4
A

Returns +
Q

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Q1 120.9% -38.8% -20.1% 6.2% 50.6% -20.4% 33% -7.8% -22.1% 51.5% -
Q2 0.2% 151.3% -46.4% -18.9% 62.2% -24.2% 4.5% -11.5% -48.8% -13.8% -
Q3 95% -51.5% -11.7% -19.7% 122.8% -28.1% 4.7% -10.6% 11.2% 8.7% -
Q4 -30.4% 3.5% 63.7% -22.1% -19.6% -62.4% -1.6% 17.9% 64.7% -40.1% -

Returns +
M

J F M A M J J A S O N D
2021 41.8% 38.7% 12.3% 1.5% -17.8% 20.1% -5.2% 108.4% -1.3% 4% -21.4% -14.8%
2020 -12.7% -21% -11.3% 20.4% 44% 44.9% -8.6% -26.3% -28.1% -13.3% 36.2% -12.4%

Returns +
A

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
DVAX 225%-23%-37%-51%373%-84%43%-14%-31%-14%4%

Annual
Returns

52 Week
High/Low

Earnings

Chart